• Six Years After Acquisition, Roche Quietly Shutters 454

    Oct 16, 2013, 10:15 AM by Michael Croft
    Bio-IT World News Brief | This month, Roche began the process of closing its wholly-owned subsidiary 454 Life Sciences, a once-dominant player in next-generation sequencing.
    Full story
  • A Daughter's Data: More on 23andMe and Privacy

    Oct 16, 2013, 09:00 AM by Michael Croft
    FastCompany | In another 23andMe profile, an author submits a sample from her adopted daughter and gets some of the most challenging results.
    Full story
  • A New Method of Attack Against Cancer: Old Age

    Oct 15, 2013, 07:45 AM by Michael Croft
    Nature Communications | Researchers at the University of Massachusetts Medical School believe it may be possible to stop tumor cells from proliferating by teaching them how to age again.
    Full story
  • Changing the Terms of Antibiotic Discovery

    Oct 14, 2013, 08:00 AM by Michael Croft
    Nature Chemical Biology | Researchers from McMaster University are bypassing traditional drug discovery methods by targeting the processes through which bacteria synthesize and metabolize nutrients, hoping to find new antibiotic compounds that could destroy pathogens in vivo even though these drugs would not work in the ideal nutrient-rich conditions usually tested in the lab.
    Full story
  • Human Variome Project Expands in Southeast Asia

    Oct 11, 2013, 11:00 AM by Michael Croft
    Bio-IT World News Brief | The Human Variome Project has launched a Southeast Asian node to facilitate the sharing of genetic variations in Southeast Asian populations.
    Full story
  • MolecularHealth Enters the American Cancer Genomics Market

    Oct 11, 2013, 08:05 AM by Michael Croft
    Bio-IT World | MolecularHealth, which just announced the management team for its North American Office, is preparing to launch a personalized, direct-to-consumer genomic service for cancer patients in the Unites States.
    Full story
  • One Simple Rule Could Regulate Structural Neuroplasticity

    Oct 10, 2013, 17:10 PM by Michael Croft
    PLOS Computational Biology | Researchers have proposed a simple homeostatic rule to explain the process by which new neural connections are established and damage to the brain is repaired.
    Full story
  • Genetic Witnesses to European Prehistory

    Oct 10, 2013, 14:15 PM by Michael Croft
    Science | A large study of ancient mitochondrial DNA is helping to reconstruct the migration patterns of Europeans during the transition from hunter-gatherer to agricultural lifestyles.
    Full story
  • Lilly Scientists Steal Trade Secrets

    Oct 10, 2013, 07:00 AM by Michael Croft
    Indianapolis Business Journal | Two Lilly scientists emailed details about nine experimental drug research programs to an individual employed by Jiangsu Hengrui Medicine Co. Ltd., based in China.
    Full story
  • A New Round of Fundraising for Oxford Nanopore

    Oct 9, 2013, 13:30 PM by Michael Croft
    Bio-IT World News Brief | Oxford Nanopore Technologies Ltd. today announced $64 million in new funds, raised from a multinational mix of current and new investors.
    Full story
  • Our Genomes Are Talking to Us - Are We Good Listeners?

    Oct 8, 2013, 15:15 PM by Michael Croft
    Bio-IT World | Two large-scale surveys, the Coriell Personalized Medicine Collaborative and the Impact of Personal Genomics Study, have been peering into consumer responses to genomic test results. Now they're delivering insights into the mindsets and health behaviors of patients who seek out whole genome sequencing.
    Full story
  • September News and Product Briefs

    Oct 8, 2013, 08:50 AM by Michael Croft
    Bio-IT World | News briefs and product releases from around the industry, including BGI's American expansion, Virtify's streamlined process for submitting clinical trials, new software for measuring gene expression and hardware for live cell assays, and much more.
    Full story
  • Predicting the Future for Non-Invasive Prenatal Testing

    Oct 7, 2013, 13:00 PM by Michael Croft
    Bio-IT World | The field of non-invasive prenatal testing is rapidly advancing thanks to tests from groups like Natera, Berry Genomics, Verinata, recently acquired by Illumina, and others. Using cell-free DNA and circulating fetal cells, researchers are able to predict diseases more accurately than ever before.
    Full story
  • A Color Portrait of the Transcriptome in Thousands of Cells

    Oct 7, 2013, 09:50 AM by Michael Croft
    Nature Methods | A new technique is allowing researchers at the University of Zurich to visualize the quantity and location of transcript molecules inside thousands of functioning cells at once.
    Full story
  • New Big Data Solutions at Sanger Institute

    Oct 7, 2013, 09:05 AM by Michael Croft
    Bio-IT World | DataDirect Networks today announced an expanded partnership with the Wellcome Trust Sanger Institute, to deploy more than 10 petabytes of high-performance storage.
    Full story
  • Updates on England's UK100K Project

    Oct 4, 2013, 12:00 PM by Michael Croft
    Genomes Unzipped | Genomics England Limited, the company built to manage the UK's plan to sequence 100,000 whole genomes over the next 3-5 years, held a town hall meeting yesterday to address some of the community's questions about the plan.
    Full story
  • Open Access Under Review

    Oct 4, 2013, 12:00 PM by Michael Croft
    Science Science magazine writer John Bohannon takes on open access publishing with a spoof paper submitted to 304 open access, "peer-reviewed" journals.
    Full story
  • A Government Scientist Speaks About the Shutdown

    Oct 3, 2013, 14:00 PM by Michael Croft
    Wired | A government biomedical scientist was instructed not to speak to the media, but she shared her thoughts on the shutdown, her research, and what damage even a temporary halt in research can do.
    Full story
  • Gene Deletions May Be Implicated in Autism

    Oct 3, 2013, 11:00 AM by Michael Croft
    Bio-IT World | A team from the Seaver Autism Center at Mt. Sinai has released the results of a large genomic study of ASD individuals, leveraging new technology to find single-gene deletions within whole exome sequences.
    Full story
  • 23andMe's Old Patents

    Oct 3, 2013, 07:00 AM by Michael Croft
    Wired | In December 2008, 23andMe received a US patent on a system for helping prospective parents choose traits for their offspring including hair color and disease risk.
    Full story